Nevertheless, the tumor microenvironment can be also targeted, e.g., CXCR4+ TEC was targeted by AMD3100 to induce tumor angiogenic inhibition triggered necrosis (TAITN) [134]. This evidence concerns the gene CXCR4 and neoplasm.